Delivery Order SPE2DB24D2205-SPE2DB25FEHYF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,748.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,846.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count). This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,789.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded under an existing Indefinite Delivery Contract (IDC). The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,862.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract type. The award, issued on July 9, 2025, with an ultimate completion date of July 10, 2025, represents a non-set-aside competitive procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $25,599.93, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,066.34 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The contract was competitively awarded without set-aside designations and carries an ultimate completion date of September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,751.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-unit quantity) under a firm fixed-price contract. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-competitive delivery order issued without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,177.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, non-set-aside contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHYFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,724.80 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on September 23, 2025, represents a non-competitive delivery order with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same municipality. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order for Eliquis, an anticoagulant medication commonly used in military and veteran healthcare systems, demonstrates the company's role as a critical vendor within the DLA's Medical Supply Chain supporting Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 9/23/25 |